Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus alprazolam for sedation and anxiety control in conscious COVID-19 ICU patients
IRCT20211015052773N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anxiety disorder comparing Clonidine with Alprazolam (2 arms). Primary endpoints: Change in anxiety state according to NVRS scale, Hypotension occurrence and 2 more. Started Nov 2021; status: completed.
02
Drugs
clonidinealprazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20211015052773N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211015052773N1.